← Eichor
Condition: Endometrial Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Endometrial Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06413992Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoin
NA · 1 location(s) · Peking University People's Hospital · NCT07318727Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemothera
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04997096Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
NA · 1 location(s) · Siriraj Hospital · NCT07595224Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NA · 1 location(s) · Jessica D. St. Laurent, MD · NCT07220239Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · 15 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472Multimedia Aid for Genetic Testing in Gynecologic Oncology
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07084168Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Phase N/A · 1 location(s) · National Cancer Institute, Naples · NCT06893861TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
Phase 2 · 1 location(s) · Fudan University · NCT06914297Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unr
Phase 1 · 1 location(s) · Aaron Wolfson · NCT05603910Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vagin
Phase N/A · 3 location(s) · University of Aarhus · NCT07400835Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT05914974Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
NA · 1 location(s) · Peking University People's Hospital · NCT06169449Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
Phase 2 · 2 location(s) · Panagiotis Konstantinopoulos, MD, PhD · NCT06518564A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Phase 2 · 16 location(s) · MacroGenics · NCT06730347Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P
Phase N/A · 2 location(s) · M.D. Anderson Cancer Center · NCT07382583Application of da Vinci SP for Endometrial Cancer Surgical Staging
Phase N/A · 3 location(s) · National Cancer Institute, Naples · NCT07027046ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07270666Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
Phase N/A · 1 location(s) · Region Västerbotten · NCT05855941Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
NA · 2 location(s) · McGill University · NCT04891029PErsonalized TReatment for Endometrial Carcinoma
NA · 1 location(s) · University of Helsinki · NCT05655260Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Pat
NA · 1 location(s) · Saglik Bilimleri Universitesi Gazi Yasargil Training and Res · NCT06870903GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Phase 2/Phase 3 · 2 location(s) · Xiaojun Chen · NCT05316935Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
Phase 2 · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT06561308Endometrial Cancer Lymphadenectomy Trial
NA · 61 location(s) · Philipps University Marburg · NCT03438474DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770102Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer
NA · 1 location(s) · Denise Fabian · NCT07631572Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT07527143BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Phase 1 · 4 location(s) · Bio-Path Holdings, Inc. · NCT04196257
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.